相关实验视频

Updated: May 6, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

关于对多发性硬化症和中枢神经系统抗体介导疾病的并发性影响的前性多中心研究的议定书 (COMMIT)

Sara Samadzadeh^1,2,3, Rafl Adnan^1,2, Paulina Berglova²

¹Institute of Regional Health Research and, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.

Frontiers in immunology

|July 18, 2024

概括

并发症显著影响多发性硬化症 (MS),神经髓炎光学谱障碍 (NMOSD) 和MOG抗体相关疾病 (MOGAD),影响疾病的进展和恢复. 了解这些影响对于开发更好的中枢神经系统炎症性脱髓化疾病治疗方法至关重要.

科学领域:

神经免疫学神经免疫学
神经学神经学
临床研究临床研究

背景情况:

在多发性硬化症 (MS),神经髓炎光学谱障碍 (NMOSD) 和MOG-抗体相关疾病 (MOGAD) 中,并发症很常见.
这些并发症可能会恶化神经系统的结果,阻碍恢复,加速疾病的进展,并增加残疾.
特别是血管并发症,需要研究它们对这些中枢神经系统 (CNS) 炎症性脱髓化疾病的影响.

研究的目的:

研究伴随性疾病,特别是血管疾病对MS,NMOSD和MOGAD的临床和准临床参数的影响.
确定与影响疾病进程的并发症相关的风险因素.
探索潜在的治疗目标,以改善这些条件下的结果.

主要方法:

具有纵向后续的前性多中心研究 (COMMIT).
根据年龄,性别和种族对MS,NMOSD,MOGAD和健康对照患者的分层.
在血液和脑脊液 (CSF) 中分析炎症和神经退行标志物,使用蛋白质组学,ELISA,RT-qPCR,质细胞计和单细胞RNA测序.
生物标记数据与光学连贯断层扫描 (OCT),磁共振成像 (MRI) 和使用算法分析的临床结果 (复发,残疾,生活质量) 的相关性.

主要成果:

N/A - 研究是前性的,结果待确定.

结论:

并发症是影响MS,NMOSD和MOGAD临床轨迹的重要因素.
识别并发症的影响对于个性化治疗策略至关重要.
这项研究旨在为改善中枢神经系统炎症性脱髓化疾病的管理铺平道路.

关键词:

中枢神经系统的抗体介导疾病.伴随性疾病发生率.多发性硬化症多发性硬化症骨髓类寡干细胞糖蛋白抗体与相关疾病相关的抗体.神经脊髓炎光学谱系障碍

更多相关视频

Author Spotlight: Expanding the Scope of Multiplex Immunoassays for Lyme Borreliosis Diagnostics and Pathogen Research

Author Spotlight: Expanding the Scope of Multiplex Immunoassays for Lyme Borreliosis Diagnostics and Pathogen Research

Published on: July 14, 2023

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

相关概念视频

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...

Multiple Sclerosis l: Introduction

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...